Clinical trial
Which Therapy for Acute Heart Attacks? (The WEST Study)
NCT00121446 · University of Alberta, Other · Completed
Key facts
| NCT number | NCT00121446 |
|---|---|
| Title | Which Therapy for Acute Heart Attacks? (The WEST Study) |
| Official title | Which Early ST Elevation Myocardial Infarction Therapy? The WEST Study |
| Lead sponsor | University of Alberta, Other |
| Collaborators | Hoffmann-La Roche Industry Sanofi Eli Lilly and Company |
| Status | Completed |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Myocardial Infarction |
| Intervention type | Drug, Procedure |
| Interventions | tenecteplase, enoxaparin, clopidogrel, percutaneous coronary intervention |
| Enrollment | 300 |
| Start date | Jul 1, 2003 |
| First posted | Jul 21, 2005 |
| Last update posted | May 19, 2017 |
| Countries | Canada |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: